411
Views
17
CrossRef citations to date
0
Altmetric
Review

A Pulmonary Embolism Response Team: initial experiences and future directions

, , &
Pages 481-489 | Received 27 Mar 2017, Accepted 30 May 2017, Published online: 05 Jun 2017

References

  • Stein PD, Matta F. Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism. Ccc. 2011;27(4):907–932. DOI:10.1016/j.ccc.2011.09.006
  • Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011;171(9):831–837. DOI:10.1001/archinternmed.2011.178
  • Writing Group Members, Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics-2016 update: a report from the American heart association. Circulation. 2016;133(4):e38–360. DOI:10.1161/CIR.0000000000000350
  • US OOTSG, National Heart, Lung, Blood Institute US. The surgeon general’s call to action to prevent deep vein thrombosis and pulmonary embolism.; 2008. [cited 2017 Feb 03]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK44178/.
  • Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med. 2003;163(14):1711–1717. DOI:10.1001/archinte.163.14.1711
  • Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The worcester DVT study. Arch Intern Med. 1991;151(5):933–938.
  • Courtney DM, Kline JA. Identification of prearrest clinical factors associated with outpatient fatal pulmonary embolism. Acad Emerg Med. 2001;8(12):1136–1142.
  • Pengo V, Lensing AWA, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004;350(22):2257–2264. DOI:10.1056/NEJMoa032274
  • Tapson VF, Humbert M. Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism. Proc Am Thorac Soc. 2006;3(7):564–567. DOI:10.1513/pats.200605-112LR
  • Hoeper MM, Mayer E, Simonneau G, et al. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113(16):2011–2020. DOI:10.1161/CIRCULATIONAHA.105.602565
  • Klok FA, Van Kralingen KW, Van Dijk APJ, et al. Quality of life in long-term survivors of acute pulmonary embolism. Chest. 2010;138(6):1432–1440. DOI:10.1378/chest.09-2482
  • Tavoly M, Utne KK, Jelsness-Jørgensen L-P, et al. Health-related quality of life after pulmonary embolism: a cross-sectional study. BMJ Open. 2016;6(11):e013086–10. DOI:10.1136/bmjopen-2016-013086
  • Kahn SR, Hirsch AM, Akaberi A, et al. Functional and exercise limitations after a first episode of pulmonary embolism: results of the ELOPE prospective cohort study. Chest. 2016. DOI:10.1016/j.chest.2016.11.030
  • Sista AK, Miller LE, Kahn SR, et al. Persistent right ventricular dysfunction, functional capacity limitation, exercise intolerance, and quality of life impairment following pulmonary embolism: systematic review with meta-analysis. Vasc Med. 2017;22(1):37–43. DOI:10.1177/1358863X16670250
  • Fanikos J, Rao A, Seger AC, et al. Hospital costs of acute pulmonary embolism. Am J Med. 2013;126(2):127–132. DOI:10.1016/j.amjmed.2012.07.025
  • LaMori JC, Shoheiber O, Mody SH, et al. Inpatient resource use and cost burden of deep vein thrombosis and pulmonary embolism in the United States. Clin Ther. 2015;37(1):62–70. DOI:10.1016/j.clinthera.2014.10.024
  • Cohoon KP, Leibson CL, Ransom JE, et al. Costs of venous thromboembolism associated with hospitalization for medical illness. Am J Manag Care. 2015;21(4):e255–63.
  • Provias T, Dudzinski DM, Jaff MR, et al. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995). 2014;42(1):31–37. DOI:10.3810/hp.2014.02.1089.
  • Jaff MR, McMurtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the american heart association. Circulation. 2011;123(16):1788–1830. DOI:10.1161/CIR.0b013e318214914f.
  • Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43): 3033–69–3069a–3069k. DOI:10.1093/eurheartj/ehu283.
  • Kucher N, Rossi E, De Rosa M, et al. Massive pulmonary embolism. Circulation. 2006;113(4):577–582. DOI:10.1161/CIRCULATIONAHA.105.592592
  • Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. Jacc. 1997;30(5):1165–1171. DOI:10.1016/S0735-1097(97)00319-7
  • Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000;101(24):2817–2822.
  • Wicki J, Perrier A, Perneger TV, et al. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost. 2000;84(4):548–552.
  • Jiménez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383–1389. DOI:10.1001/archinternmed.2010.199
  • Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041–1046. DOI:10.1164/rccm.200506-862OC
  • DeVita MA, Bellomo R, Hillman K, et al. Findings of the first consensus conference on medical emergency teams. Crit Care Med. 2006;34(9):2463–2478. DOI:10.1097/01.CCM.0000235743.38172.6E
  • Winters BD, Weaver SJ, Pfoh ER, et al. Rapid-response systems as a patient safety strategy. Ann Intern Med. 2013;158(5_Part_2):417–418. DOI:10.7326/0003-4819-158-5-201303051-00009
  • Maharaj R, Raffaele I, Wendon J. Rapid response systems: a systematic review and meta-analysis. Critical Care. 2015;1–15. DOI:10.1186/s13054-015-0973-y
  • Solomon RS, Corwin GS, Barclay DC, et al. Effectiveness of rapid response teams on rates of in-hospital cardiopulmonary arrest and mortality: A systematic review and meta-analysis. J Hosp Med. 2016;11(6):438–445. DOI:10.1002/jhm.2554
  • Holmes DR, Rich JB, Zoghbi WA, et al. The heart team of cardiovascular care. Jacc. 2013;61(9):903–907. DOI:10.1016/j.jacc.2012.08.1034
  • Nallamothu BK, Cohen DJ. No “I” in heart team: incentivizing multidisciplinary care in cardiovascular medicine. Circ Cardiovasc Qual Outcomes. 2012;5(3):410–413. DOI:10.1161/CIRCOUTCOMES.112.966101
  • Brush JE, Handberg EM, Biga C, et al. 2015 ACC health policy statement on cardiovascular team-based care and the role of advanced practice providers. J Am Coll Cardiol. 2015;65(19):2118–2136. DOI:10.1016/j.jacc.2015.03.550
  • Serruys PW, Morice M-C, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–972. DOI:10.1056/NEJMoa0804626
  • Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update. Jacc. 2012;59(9):857–881. DOI:10.1016/j.jacc.2011.12.001
  • Holmes DR, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. Jacc. 2012;59(13):1200–1254. DOI:10.1016/j.jacc.2012.01.001
  • Witkin A, Harshbarger S, Kabrhel C. Pulmonary embolism response teams. Semin Thromb Hemost. 2016;42(08):857–864. DOI:10.1055/s-0036-1593541
  • Reza N, Dudzinski DM. Pulmonary embolism response teams. Curr Treat Options Cardio Med. 2015;17(6):27–29. DOI:10.1007/s11936-015-0387-9
  • Kabrhel C, Rosovsky R, Channick R, et al. A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest. 2016;150(2):384–393. DOI:10.1016/j.chest.2016.03.011.
  • Smith SB, Geske JB, Maguire JM, et al. Early anticoagulation is associated with reduced mortality for acute pulmonary embolism. Chest. 2010;137(6):1382–1390. DOI:10.1378/chest.09-0959
  • Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352. DOI:10.1016/j.chest.2015.11.026.
  • Kline JA, Nordenholz KE, Courtney DM, et al. Treatment of submassive pulmonary embolism with tenecteplase or placebo: cardiopulmonary outcomes at 3 months: multicenter double-blind, placebo-controlled randomized trial. J Thromb Haemost. 2014;12(4):459–468. DOI:10.1111/jth.12521
  • Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. New England J Med. 2014;370(15):1402–1411. DOI:10.1056/NEJMoa1302097
  • Sharifi M, Bay C, Skrocki L, et al. “MOPETT” Investigators. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol. 2013;111(2):273–277. DOI:10.1016/j.amjcard.2012.09.027
  • Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605–614. DOI:10.1093/eurheartj/ehu218
  • Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage. Jama. 2014;311(23):2414–2418. DOI:10.1001/jama.2014.5990
  • Gao G-Y, Yang P, Liu M, et al. Thrombolysis for acute intermediate-risk pulmonary embolism: A meta-analysis. Thromb Res. 2015;136(5):932–937. DOI:10.1016/j.thromres.2015.09.012
  • Nakamura S, Takano H, Kubota Y, et al. Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis. J Thromb Haemost. 2014;12(7):1086–1095. DOI:10.1111/jth.12608
  • Samoukovic G, Malas T, de Varennes B. The role of pulmonary embolectomy in the treatment of acute pulmonary embolism: a literature review from 1968 to 2008. Interact Cardiovasc Thorac Surg. 2010;11(3):265–270. DOI:10.1510/icvts.2009.228361
  • Stein PD, Alnas M, Beemath A, et al. Outcome of pulmonary embolectomy. Am J Cardiol. 2007;99(3):421–423. DOI:10.1016/j.amjcard.2006.08.050
  • Neely RC, Byrne JG, Gosev I, et al. Surgical embolectomy for acute massive and submassive pulmonary embolism in a series of 115 patients. Ann Thorac Surg. 2015;100(4): 1245–51–discussion 1251–2. DOI:10.1016/j.athoracsur.2015.03.111
  • Stein PD, Matta F. Case fatality rate with pulmonary embolectomy for acute pulmonary embolism. Am J Med. 2012;125(5):471–477. DOI:10.1016/j.amjmed.2011.12.003
  • Kucher N, Boekstegers P, Muller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014;129(4):479–486. DOI:10.1161/CIRCULATIONAHA.113.005544
  • Piazza G, Hohlfelder B, Jaff MR, et al. A prospective, single-arm, multicenter trial of ultrasound-facilitated, catheter-directed, low-dose fibrinolysis for acute massive and submassive pulmonary embolism: the seattle II study. JACC Cardiovasc Interv. 2015;8(10):1382–1392. DOI:10.1016/j.jcin.2015.04.020
  • Kuo WT, Banerjee A, Kim PS, et al. Pulmonary Embolism Response to Fragmentation, Embolectomy, and Catheter Thrombolysis (PERFECT): initial results from a prospective multicenter registry. Chest. 2015;148(3):667–673. DOI:10.1378/chest.15-0119.
  • Bloomer TL, El-Hayek GE, McDaniel MC, et al. Safety of catheter-directed thrombolysis for massive and submassive pulmonary embolism: results of a multicenter registry and meta-analysis. Catheter Cardiovasc Interv. 2017;35:3145. DOI:10.1002/ccd.26900
  • Liang NL, Avgerinos ED, Marone LK, et al. Comparative outcomes of ultrasound-assisted thrombolysis and standard catheter-directed thrombolysis in the treatment of acute pulmonary embolism. Vasc Endovascular Surg. 2016;50(6):405–410. DOI:10.1177/1538574416666228
  • Jaber WA, Fong PP, Weisz G, et al. Acute pulmonary embolism: with an emphasis on an interventional approach. J Am Coll Cardiol. 2016;67(8):991–1002. DOI:10.1016/j.jacc.2015.12.024
  • Donaldson CW, Baker JN, Narayan RL, et al. Thrombectomy using suction filtration and veno-venous bypass: single center experience with a novel device. Catheter Cardiovasc Interv. 2015;86(2):E81–7. DOI:10.1002/ccd.25583
  • Weinberg AS, Dohad S, Ramzy D, et al. Clot extraction with the flowtriever device in acute massive pulmonary embolism. J Intensive Care Med. 2016. DOI:10.1177/0885066616666031
  • Yusuff HO, Zochios V, Vuylsteke A. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a systematic review. Perfusion. 2015;30(8):611–616. DOI:10.1177/0267659115583377
  • Carroll BJ, Shah RV, Murthy V, et al. Clinical features and outcomes in adults with cardiogenic shock supported by extracorporeal membrane oxygenation. Am J Cardiol. 2015;116(10):1624–1630. DOI:10.1016/j.amjcard.2015.08.030
  • Weinberg I, Kaufman J, Jaff MR. Inferior vena cava filters. JACC Cardiovasc Interv. 2013;6(6):539–547. DOI:10.1016/j.jcin.2013.03.006
  • Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d’Embolie Pulmonaire par interruption cave study group. New England J Med. 1998;338(7):409–415. DOI:10.1056/NEJM199802123380701
  • Mismetti P, Laporte S, Pellerin O, et al. Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism. Jama. 2015;313(16):1627–1629. DOI:10.1001/jama.2015.3780
  • Barnes GD, Kabrhel C, Courtney DM, et al. Diversity in the pulmonary embolism response team model: an organizational survey of the national pert consortium members. Chest. 2016;150(6):1414–1417. DOI:10.1016/j.chest.2016.09.034

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.